Douglas P. Zipes MD
Distinguished Professor, Professor Emeritus of Medicine, Pharmacology and Toxicology, Emeritus Director of the Division of Cardiology and Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IndianaDr. Douglas P. Zipes is Distinguished Professor, Professor Emeritus of Medicine, Pharmacology and Toxicology, and Emeritus Director of the Division of Cardiology and Krannert Institute of Cardiology at Indiana University School of Medicine. He received his medical degree from Harvard Medical School and trained at Duke University Medical Center in medicine and cardiology. He joined Indiana University in 1970, became Distinguished Professor in 1994, and then Director of Cardiology (1995–2004).
Having published almost 1000 medical articles and 16 textbooks with multiple editions, Dr. Zipes is the recipient of numerous awards from the American Heart Association, the Heart Rhythm Society, the American College of Cardiology, and the European Society of Cardiology, among other professional societies and institutions.
He is past president of the American College of Cardiology and the Heart Rhythm Society, and past chair of the American Board of Internal Medicine. He is a fellow of the Heart Rhythm Society, American Heart Association, European Society of Cardiology. He is Master of the American College of Physicians and American College of Cardiology, and he is a member of the American Society for Clinical Investigation and the Association of American Physicians. In addition, Dr. Zipes retains honorary membership in the Cardiac Society of Australia and New Zealand, Argentine Society of Cardiology, Hungarian Society of Cardiology, and Israel Heart Society.
Recent Contributions to PracticeUpdate:
- Ablation vs Antiarrhythmic Drugs as First-Line in Paroxysmal Atrial Fibrillation
- Atrial Tissue Fibrosis Associated With Increased Risk of Recurrent Arrhythmia
- Incidence and Significance of Atrial Fibrillation Early Recurrence Following Cryoballoon Ablation
- Morbidity and Mortality With RF Catheter Ablation for Atrial Fibrillation
- Pacing After Cardiac Device Replacement
- Periprocedural Anticoagulation With Uninterrupted Rivaroxaban in Patients Undergoing RFA for Atrial Fibrillation
- Rate vs Rhythm Control After Ablation for AFib With Impaired LV Systolic Function
- Catheter Ablation Effective in Selected Patients With AFib and HF
- Renal Denervation: Novel Treatment for Ventricular Tachycardia Storm in Cardiomyopathy
- Late Outcomes for Permanent Pacemaker Implantation Following TAVI